Back to Search Start Over

Myelosuppression by sunitinib is flt-3 genotype dependent.

Authors :
van Erp, N. P.
Mathijssen, R. H. J.
van der Veldt, A. A.
Haanen, J. B.
Reyners, A. K. L.
Eechoute, K
Boven, E
Wessels, J. A. M.
Guchelaar, H-J
Gelderblom, H
Source :
British Journal of Cancer; 8/24/2010, Vol. 103 Issue 5, p757-758, 2p, 1 Graph
Publication Year :
2010

Abstract

A letter to the editor is presented regarding a study which found that flt-3 polymorphism is associated with the risk of having leukopenia following treatment with sunitinib.

Details

Language :
English
ISSN :
00070920
Volume :
103
Issue :
5
Database :
Complementary Index
Journal :
British Journal of Cancer
Publication Type :
Academic Journal
Accession number :
53060163
Full Text :
https://doi.org/10.1038/sj.bjc.6605813